The role of vitamin D in the treatment of nerve pain in diabetes

Phase 2

Recruiting

• Conditions: europathic pain in type 2 diabetes; Neuropathic pain in type 2 diabetes; Metabolic and Endocrine - Diabetes; Neurological - Other neurological disorders

• Registration Number: ACTRN12610000322033
• Lead Sponsor: St Vincent's Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-04-21
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with type 2 diabetes and with painful neuropathy with a serum 25-hydroxyvitamin D level of less than 50 nmol/

Exclusion Criteria

Patients with type 1 or secondary diabetes, hypercalcaemia or renal stone

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain scores on questionnaires (visual analogue scale, McGill short form pain questionnaire)[baseline and at 3 months and 6 months following randomisation]

Secondary Outcome Measures

Name	Time	Method
Quality of life (SF-36)[Baseline and 3 months and 6 months following randomisation];Changes in severity of neuropathy on clinical examination and by biothesiometry.[Baseline and 3 months and 6 months after randomisation]